Media formats available:
Recommended
- AHA 2019A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial
Prof. Freek Verheugt, MD
Prof. Stephen Nicholls
Prof. Mikhail Kosiborod
Prof. Lawrence Leiter, MD
Prof. Freek Verheugt, MD
Prof. Stephen Nicholls
Prof. Mikhail Kosiborod
Prof. Lawrence Leiter, MD